	Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma. Thorac Cancer Niedermaier B, Allgäuer M, Muley T, Schneider MA, Eichhorn ME, Winter H, Klotz LV. PMID: 39807578 [PubMed - indexed for MEDLINE]
	Efficacy evaluation of prophylactic cranial irradiation for limited stage smallâ€‘cell lung cancer in the magnetic resonance imaging era: A metaâ€‘analysis. Oncol Lett Shao L, Dong Y, Jiang M, Song H, Qi Y, Guo L, Tian J, Wei S. PMID: 39807106 [PubMed]
	Zerumbone Induces Apoptosis in Non-Small-Cell Lung Cancer via Biomolecular Alterations: A Microscopic andÂ Spectroscopic Study. J Biophotonics Köprü ÇZ, Baba B, Yonar D. PMID: 39807038 [PubMed - as supplied by publisher]
	Long-Term Real-World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score-Matched Analysis. Thorac Cancer Kim K, Sweeting M, Jönsson L, Wilking N. PMID: 39806827 [PubMed - indexed for MEDLINE]
	Comparison of the Efficacy and Safety of PD-1/PD-L1 Inhibitors in the Treatment of Small Cell Lung Cancer. Cancer Rep (Hoboken) Zhang Q, Han X, Liu J, Qiao H. PMID: 39806774 [PubMed - indexed for MEDLINE]
	Association between forced expiratory volume in 1 s and relapse-free survival in operable non-small cell lung cancer: a prospective cohort study with propensity score overlap weighting. BMJ Open Wu S, Fu S, Ripley-Gonzalez JW, Cui N, Du Y, Sylvester K, You B, Xu N, Cheng J, Dun Y, Liu S. PMID: 39806653 [PubMed - indexed for MEDLINE]
	Thoracic perfusion of antiangiogenic agents combined with chemotherapy for treating malignant pleural effusion in non-small cell lung cancer: a network meta-analysis. BMJ Open Xu Y, Cui Y, Jiang L, Yu Y, Si W, Zhu X. PMID: 39806648 [PubMed - indexed for MEDLINE]
	The MyLungHealth study protocol: a pragmatic patient-randomised controlled trial to evaluate a patient-centred, electronic health record-integrated intervention to enhance lung cancer screening in primary care. BMJ Open Kukhareva P, Balbin C, Stevens E, Mann D, Tiase V, Butler J, Del Fiol G, Caverly T, Kaphingst K, Schlechter CR, Fagerlin A, Li H, Zhang Y, Hess R, Flynn M, Reddy C, Warner P, Choi J, Martin D, Nanjo C, Metzger Q, Kawamoto K. PMID: 39806641 [PubMed - indexed for MEDLINE]
	Awake thoracic surgery for lung cancer treatment: where we are and future perspectives-our experience and review of literature. J Cardiothorac Surg Mugnaini G, Tombelli S, Burlone A, Bongiolatti S, Viggiano D, Indino R, Salimbene O, Gatteschi L, Voltolini L, Gonfiotti A. PMID: 39806444 [PubMed - indexed for MEDLINE]
	AMPK: an energy sensor for Non-small cell lung cancer progression and treatment. Pharmacol Res Zhong ZT, Wang XY, Pan Y, Zhou K, Chen JH, Gao YQ, Dai B, Zhou ZL, Wang RQ. PMID: 39805353 [PubMed - as supplied by publisher]
	Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib. Ann Oncol Horinouchi H, Cho BC, Camidge DR, Goto K, Tomasini P, Li Y, Vasilopoulos A, Brunsdon P, Hoffman D, Shi W, Bolotin E, Blot V, Goldman J. PMID: 39805351 [PubMed - as supplied by publisher]
	Census Tract Rurality, Predominant Race and Ethnicity, and Distance to Lung Cancer Screening Facilities : An Ecological Study. Ann Intern Med Amiri S, Wilshire CL, Muller CJ, Allick C, Welch AC, Ferguson G, Buchwald D, Gorden JA. PMID: 39805114 [PubMed - as supplied by publisher]
	Effects of Brucea Javanica Oil Combined with Chemotherapy on Serum CYFRA21-1, Immune Mechanism and Prognosis in Lung Cancer Patients. Altern Ther Health Med Ma Y, Yang X, Agudamu W, Liu X, Zhao B. PMID: 39804995 [PubMed - as supplied by publisher]
	Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial. JAMA Intern Med Cinciripini PM, Minnix JA, Kypriotakis G, Erasmus J, Beneventi D, Karam-Hage M, Carpenter K, Volk RJ, Carter B, Godoy MCB, Strange C, Shih YT, Cui Y, Green CE, Robinson JD. PMID: 39804633 [PubMed - as supplied by publisher]
	Cost-effectiveness analysis of PD-L1 testing associated with pembrolizumab for first-line treatment of advanced non-small cell lung cancer in China. Int J Clin Pharm Wu Y, Tao L, Liu C, Wang F, Sun S. PMID: 39804416 [PubMed - as supplied by publisher]
	Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback. Psychooncology Derry-Vick H, Khoudary A, Billini O, Prigerson HG, Schwartz MD, Cohen J, Griffin C, Gutierrez M, Lichtenthal WG, Carter-Bawa L. PMID: 39804222 [PubMed - indexed for MEDLINE]
	Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial. Clin Cancer Res Negrao MV, Paula AG, Molkentine D, Hover L, Nilsson M, Vokes N, Engstrom L, Calinisan A, Briere DM, Waters L, Hallin J, Diao L, Altan M, Blumenschein GR, Skoulidis F, Wang J, Kopetz SE, Hong DS, Gibbons DL, Olson P, Christensen JG, Heymach JV. PMID: 39804166 [PubMed - as supplied by publisher]
	Evaluation of End-of-Life Quality Care Between American Indian and White North Carolina Decedents Diagnosed With Lung Cancer, 2003-2020. JCO Oncol Pract Jackson BE, Baggett CD, Spees LP, Carrizosa D, Emerson MA, Fariman S, Salas AI, Bell RA, Wheeler SB. PMID: 39803996 [PubMed - as supplied by publisher]
	Risk factors for mediastinal lymph node metastases in early-stage non-small-cell lung cancer and prediction model establishment. Am J Cancer Res Tang Y, Garu A, Chen X, Guan Z, Cai X, Huang H, Xitao L, Tang K, Dong Y. PMID: 39803641 [PubMed]
	Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitors for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer. Infect Drug Resist Wang H, Gao L, Cai X, Li J, Lang Y, Zheng R, Yang S. PMID: 39803310 [PubMed]

Articles 1 - 20 / 144017

Page 1 of 7201



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy